Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio? Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners experiencing significant growth due to strategic developments.
What's Going On With Brighthouse Financial Shares Tuesday? Brighthouse Financial shares are moving higher on Tuesday following a report suggesting that the company is exploring a potential sale.
Billionaire Hedge Fund Manager David Einhorn Says Stock Market Is Fundamentally Broken: Here's Why Billionaire David Einhorn explains why he believes the market is fundamentally broken and how it's affecting smaller companies and ETFs.
BHF Stock Earnings: Brighthouse Finl Beats EPS, Misses Revenue for Q2 2024 BHF stock results show that Brighthouse Finl beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
MetLife-Spinoff Brighthouse Financial Impresses Analyst With Business Mix Improvements Analyst upgrades Brighthouse Financial, citing gradual business mix improvement and strong capital position. Stock has lost 23% YTD but trading at reasonable free cash flow yield.
3 Sorry Insurance Stocks to Sell in May While You Still Can Despite being in a period of economic uncertainty, higher rates and higher premiums, these insurance stocks to sell are underperforming.
BHF Stock Earnings: Brighthouse Finl Beats EPS, Misses Revenue for Q1 2024 BHF stock results show that Brighthouse Finl beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
David Einhorn Has 47% of His Portfolio Invested in These 3 Stocks These three David Einhorn stocks comprise the largest long positions in a portfolio mostly known for the short sales it has made.
